AUROLIFE PHARMA LLC FDA Approval ANDA 072484

ANDA 072484

AUROLIFE PHARMA LLC

FDA Drug Application

Application #072484

Application Sponsors

ANDA 072484AUROLIFE PHARMA LLC

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL50MG0TRAZODONE HYDROCHLORIDETRAZODONE HYDROCHLORIDE

FDA Submissions

ORIG1AP1990-04-30
LABELING; LabelingSUPPL2AP1992-05-21
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1995-04-26
LABELING; LabelingSUPPL4AP1996-05-03
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1997-04-25
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1999-09-10
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1999-05-05
LABELING; LabelingSUPPL8AP1999-09-10
LABELING; LabelingSUPPL9AP2000-08-30
MANUF (CMC); Manufacturing (CMC)SUPPL10AP2001-09-17
MANUF (CMC); Manufacturing (CMC)SUPPL11AP2001-05-09
LABELING; LabelingSUPPL14AP2014-07-18STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL3Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL10Null0
SUPPL11Null0
SUPPL14Null7

CDER Filings

AUROLIFE PHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 72484
            [companyName] => AUROLIFE PHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"TRAZODONE HYDROCHLORIDE","activeIngredients":"TRAZODONE HYDROCHLORIDE","strength":"50MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"TRAZODONE HYDROCHLORIDE","submission":"TRAZODONE HYDROCHLORIDE","actionType":"50MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.